Today, Chairman John Moolenaar (R-MI) of the Select Committee on China and Congresswoman Debbie Dingell (D-MI) introduced the Biotech Investment National Security Act (BINSA). This legislation would ensure American investment in adversary biotechnology is subject to the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act. This would apply to biotechnology, including pharmaceutical development, biologics manufacturing, and clinical research and development.
Select Committee Chairman John Moolenaar made the following statement on the Trump Administration’s decision to block the sale of export-controlled chips to Chinese companies located outside of mainland China:
“Winning the AI race against China requires commonsense export controls that are strictly enforced. The Trump Administration is right to close this loophole—a Chinese company anywhere in the world is subject to the CCP’s national security laws, and it should never be able to get ahold of advanced chips that its parent company in China is legally prohibited from buying. My SCALE Act complements this action by creating a clear export control standard to help secure America’s technology edge in line with President Trump’s AI Action Plan.”
Earlier this month, Chairman John Moolenaar of the Select Committee on China released a new report examining NASA’s research security compliance a
Chairman John Moolenaar of the Select Committee on China has sent a letter to Secretary of Treasury Scott Bessent urging him to add biotechnology as a prohibited technology under the Comprehensive Outbound Investment National Security (COINS) Act of 2025. The request comes in response to a dangerous surge of American capital and knowledge into China’s biotechnology sector, including Bristol Myers Squibb’s recently announced $15 billion deal with China’s Hengrui Pharma that also transfers intellectual property to China.
Chairman John Moolenaar of the Select Committee on China has sent a letter to Secretary of Treasury Scott Bessent urging him to add biotechnology as a prohibited technology under the Comprehensive Outbound Investment National Security (COINS) Act of 2025. The request comes in response to a dangerous surge of American capital and knowledge into China’s biotechnology sector, including Bristol Myers Squibb’s recently announced $15 billion deal with China’s Hengrui Pharma that also transfers intellectual property to China.
A new Select Committee on China investigation found JPMorgan Chase and Bank of America helped a Chinese company with ties to forced labor and China’s military raise billions of dollars. Just months after the Department of War designated Contemporary Amperex Technology Co., Ltd. (CATL) as a Chinese military company, both banks underwrote CATL’s initial public offering (IPO) on the Hong Kong stock exchange, where the company raised new capital.
A new Select Committee on China investigation found JPMorgan Chase and Bank of America helped a Chinese company with ties to forced labor and China’s military raise billions of dollars.
Select Committee on China Chairman John Moolenaar and Ranking Member Ro Khanna released a new investigation exposing a vast, China-linked scam center network that has defrauded Americans of at least $10 billion annually while fueling human trafficking, cybercrime, and illicit finance.
The Select Committee found that the scam centers concentrated in southeast Asia, particularly in Cambodia and Burma, are part of a distributed criminal ecosystem linking cyber fraud, human trafficking, and money laundering.
Today, Select Committee on China Chairman John Moolenaar and Ranking Member Ro Khanna released a new investigation exposing a vast, China-linked scam center network that has defrauded Americans of at least $10 billion annually while fueling human trafficking, cybercrime, and illicit finance.
“These scam centers with deep links to China are a broad network of fraud, human trafficking, cybercrime, and illicit finance that are ripping off Americans and threatening our national security,” warned Moolenaar. “If the Chinese government wanted to act against these criminals, it could, but it chooses not to.”
Today, Select Committee on China Chairman John Moolenaar delivered his opening statement at the Select Committee’s hearing titled “Crime, Corruption, and Power: The Rise of CCP-linked Scam Networks Targeting Americans and Threatening U.S. Security.”
---------------------------------------------------------------------------------------------
Good morning.
Our nation confronts one of the fastest-growing and largest financial threats facing Americans: the industrial-scale scam and fraud ecosystem fueled by China and enabled by corruption, weak governance, and illicit finance in Southeast Asia.
In 2024, Americans lost at least $10 billion to these scams. That’s $10 billion—with a B.